Spero Therapeutics, Inc. (SPRO)

NMS – Real Time Price. Currency in USD

2.54

-0.01 (-0.39%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

60M

27M

97M

49M

Cost of goods sold

-2K

-367K

-2M

Gross Profit

27M

96M

47M

Operating expenses (excl. COGS)

-60M

-120M

-77M

-83M

Operating Income

-24K

-93M

20M

-35M

Non-operating income, total

24M

-11M

Pretax income

-69M

25M

-46M

Equity in earnings

Taxes

-261K

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-69M

23M

-46M

Spero Therapeutics, Inc. (SPRO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Spero Therapeutics, Inc. (SPRO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Spero Therapeutics, Inc. (SPRO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Spero Therapeutics, Inc. (SPRO)

Income Statement (Annual)

Income Statement (Annual)